Credit Capital Investments LLC bought a new stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,100 shares of the enterprise software provider's stock, valued at approximately $294,000. Oracle makes up about 0.5% of Credit Capital Investments LLC's portfolio, making the stock its 17th largest position.
A number of other institutional investors also recently made changes to their positions in ORCL. Harel Insurance Investments & Financial Services Ltd. lifted its holdings in shares of Oracle by 71.6% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 257,378 shares of the enterprise software provider's stock valued at $35,984,000 after purchasing an additional 107,404 shares in the last quarter. Rockland Trust Co. raised its holdings in Oracle by 4.8% during the first quarter. Rockland Trust Co. now owns 10,165 shares of the enterprise software provider's stock valued at $1,421,000 after buying an additional 467 shares in the last quarter. Calamos Advisors LLC boosted its position in Oracle by 1.5% during the first quarter. Calamos Advisors LLC now owns 711,290 shares of the enterprise software provider's stock worth $99,445,000 after purchasing an additional 10,426 shares during the period. Cornerstone Advisory LLC grew its stake in Oracle by 34.1% in the 4th quarter. Cornerstone Advisory LLC now owns 12,968 shares of the enterprise software provider's stock valued at $2,258,000 after buying an additional 3,299 shares during the last quarter. Finally, Peak Retirement Planning Inc. bought a new position in shares of Oracle in the fourth quarter worth about $211,000. 42.44% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other Oracle news, insider Clayton M. Magouyrk sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $214.10, for a total value of $3,211,500.00. Following the transaction, the insider owned 60,722 shares in the company, valued at approximately $13,000,580.20. This represents a 19.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Jeffrey Henley sold 400,000 shares of the stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $190.42, for a total value of $76,168,000.00. Following the completion of the transaction, the insider owned 1,097,576 shares in the company, valued at $209,000,421.92. This represents a 26.71% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 428,303 shares of company stock worth $82,480,056. 42.20% of the stock is owned by company insiders.
Analyst Ratings Changes
Several analysts have recently commented on ORCL shares. Oppenheimer restated an "outperform" rating on shares of Oracle in a report on Wednesday, June 18th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and set a $240.00 price target (up from $200.00) on shares of Oracle in a research report on Thursday, June 12th. Westpark Capital increased their target price on Oracle from $195.00 to $246.00 and gave the stock a "buy" rating in a research note on Thursday, June 12th. Royal Bank Of Canada upped their price objective on Oracle from $145.00 to $195.00 and gave the stock a "sector perform" rating in a research report on Thursday, June 12th. Finally, The Goldman Sachs Group reiterated a "neutral" rating and set a $195.00 target price (up previously from $145.00) on shares of Oracle in a report on Friday, June 13th. Nine equities research analysts have rated the stock with a hold rating, twenty-three have given a buy rating and three have given a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $218.29.
Get Our Latest Stock Report on Oracle
Oracle Trading Down 3.7%
Shares of ORCL stock opened at $244.44 on Monday. The company has a market capitalization of $686.59 billion, a price-to-earnings ratio of 56.32, a PEG ratio of 3.65 and a beta of 1.43. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 4.07. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $260.87. The firm has a 50-day moving average price of $213.55 and a 200 day moving average price of $174.96.
Oracle (NYSE:ORCL - Get Free Report) last released its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping the consensus estimate of $1.64 by $0.06. The business had revenue of $15.90 billion for the quarter, compared to analysts' expectations of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The company's revenue was up 11.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.63 earnings per share. Research analysts forecast that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, July 24th. Shareholders of record on Thursday, July 10th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.8%. The ex-dividend date was Thursday, July 10th. Oracle's payout ratio is presently 46.08%.
Oracle Company Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report